ESR1 and neoplasm: Immunohistochemical analysis of the tumor demonstrated estrogen receptor (ER) positivity in 50 % of tumor cells, while progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) were negative (scored 1+).